Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Microbot Medical Inc. (MBOT)
USD1.88
+0.01 (+0.53%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
25 Recreation Park Drive 2043
Hingham, MA, US
Hingham, MA, US
CEO
Harel Gadot
Website
microbotmedical.com
IPO
1992-03-25
CIK 883975 ISIN US59503A2042
Description
Microbot Medical Inc. operates as a pre-clinical stage medical device company, concentrating its efforts on the research, design, and development of robotic instruments for endoluminal surgery, specifically targeting the field of minimally invasive procedures. Leveraging its proprietary micro-robotic technologies, which include ViRob, TipCAT, CardioSert, and Liberty, the company is actively developing several key products. These include a Self-Cleaning Shunt intended for the treatment of hydrocephalus and normal pressure hydrocephalus, as well as a single-use robotic system designed for various endovascular interventional applications. Additionally, Microbot Medical maintains a robust, multi-generational product pipeline. Its global intellectual property portfolio is substantial, encompassing 42 granted or allowed patents and an additional 23 patent applications currently under review. The company also benefits from a strategic collaboration agreement with Stryker Corporation, focusing on joint technology development. Established in 2010, Microbot Medical Inc. is headquartered in Hingham, Massachusetts.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.88
+0.01 (+0.53%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2M
Beta
1.03
Float Shares
45.55M
Free Float %
99.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -15.44% | +4.78% | +3.30% | +9.50% | -14.12% | +82.50% | -66.77% | -99.48% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
1.88
Low
5.50
+192.6%
Consensus
5.50
+192.6%
Median
5.50
+192.6%
High
5.50
+192.6%
DCF (Unlevered)
0.07
-96.1%
DCF (Levered)
0.07
-96.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
5.50
+192.6%
|
| All Time | 1 |
5.50
+192.6%
|
Quality scores
Altman Z-Score
13.36
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
4 / 5
High
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%—
-
EPS growth Medical - Instruments & Supplies: +16.3%+60.3% ★ Q1'26: -919.7% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%— Q1'26: -4,915.2% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%— Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+192.7% Q1'26: +294.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.06× Q1'26: -0.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 1997 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
10.60M
est: 104.57M (-89.9%)
|
117.0K
est: 129.0K (-9.3%)
|
—
est: 115.0K (-100.0%)
|
—
est: 3.20M (-100.0%)
|
—
est: 6.62M (-100.0%)
|
—
est: 12.77M (-100.0%)
|
—
est: 23.77M (-100.0%)
|
—
|
—
est: 113.3K (-100.0%)
|
5.02M
3.22M – 6.83M
+4,333.0% YoY
|
10.20M
9.63M – 10.77M
+103.0% YoY
|
26.30M
24.83M – 27.77M
+157.8% YoY
|
47.60M
44.94M – 50.26M
+81.0% YoY
|
| EBITDA |
-12.10M
est: -183.40M (+93.4%)
|
-36.61M
|
-9.63M
|
-9.02M
|
-11.28M
est: -7.75M (-45.5%)
|
-13.34M
|
-10.63M
|
-11.35M
|
-14.70M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-14.20M
|
-914.0K
|
-9.64M
|
-9.09M
|
-11.36M
est: -3.76M (-202.3%)
|
-13.44M
|
-10.74M
|
-11.44M
|
-14.74M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-18.10M
est: -219.54M (+91.8%)
|
-36.42M
est: -9.47B (+99.6%)
|
-9.66M
est: -5.58B (+99.8%)
|
-9.17M
est: -19.56M (+53.1%)
|
-11.31M
est: -8.37M (-35.2%)
|
-13.17M
est: -29.73M (+55.7%)
|
-10.74M
est: -17.05M (+37.0%)
|
-11.44M
est: -11.11M (-3.0%)
|
-13.14M
est: -13.74M (+4.3%)
|
-15.57M
-16.70M – -14.44M
-13.4% YoY
|
-15.57M
-16.70M – -14.44M
+0.0% YoY
|
-11.45M
-12.28M – -10.62M
+26.5% YoY
|
-2.29M
-2.46M – -2.12M
+80.0% YoY
|
| SGA |
6.20M
est: 93.07M (-93.3%)
|
9.33M
|
8.77M
|
5.89M
|
5.41M
est: 4.65M (+16.3%)
|
5.58M
|
4.13M
|
5.00M
|
8.46M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-17,496.00
est: -10,546.20 (-65.9%)
|
-12.58
est: -605.34 (+97.9%)
|
-10.14
est: -356.40 (+97.2%)
|
-1.29
est: -1.25 (-3.2%)
|
-1.59
est: -1.59 (+0.0%)
|
-1.81
est: -1.90 (+4.7%)
|
-1.05
est: -1.09 (+3.7%)
|
-0.73
est: -0.71 (-2.8%)
|
-0.29
est: -0.30 (+3.3%)
|
-0.35
-0.36 – -0.32
-15.0% YoY
|
-0.34
-0.36 – -0.32
+1.4% YoY
|
-0.25
-0.27 – -0.23
+26.5% YoY
|
-0.05
-0.05 – -0.05
+80.0% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-12 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-11 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 3/5 |
| 2026-05-08 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | C+ | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C | 2/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-9.35M
OE per share TTM
-1.32
Owner's Yield
-6.36%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
7,456.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
28
Total invested
11.72M
Insider transactions (90d)
0
Beneficial owners (>5%)
30
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 13G | 8.33M | 6.00% | — | 8.33M | — | 8.33M | HC, OO | Texas | 2016-03-16 | ↗ |
| 2 | BlackRock for purposes of Schedule 13G filings. | 6.95M | 5.87% | 6.95M | — | 6.95M | — | HC | Delaware | 2010-01-29 | ↗ |
| 3 | LSA- Life Science Accelerator Ltd. | 5.31M | 19.47% | — | 5.31M | — | 5.31M | OO | Israel | 2017-01-09 | ↗ |
| 4 | Yoseph Bornstein | 5.31M | 19.47% | — | 5.31M | — | 5.31M | IN | Israel | 2017-01-09 | ↗ |
| 5 | Berkson | 4.31M | 12.94% | — | 4.31M | — | 4.31M | IN | Austria | 2017-06-20 | ↗ |
| 6 | Holding GmbH | 4.31M | 12.94% | — | 4.31M | — | 4.31M | OO | Austria | 2017-06-20 | ↗ |
| 7 | Sabby Healthcare Volatility Master Fund, Ltd. | 3.85M | 5.61% | — | 3.85M | — | 3.85M | CO | Cayman Islands | 2014-07-17 | ↗ |
| 8 | (1) BlackRock, Inc. | 3.30M | 2.40% | 3.30M | — | 3.30M | — | HC | Delaware | 2011-07-08 | ↗ |
| 9 | Merril Lynch Growth Fund | 2.76M | 15.50% | — | 2.76M | — | 2.76M | IV | Maryland | 1998-02-04 | ↗ |
| 10 | Merrill Lynch Asset Management, L.P. | 2.76M | 15.50% | — | 2.76M | — | 2.76M | IA, PN | Delaware | 1998-02-04 | ↗ |
| 11 | Princeton Services, Inc. | 2.76M | 15.50% | — | 2.76M | — | 2.76M | HC, CO | Delaware | 1998-02-04 | ↗ |
| 12 | Moshe Shoham | 2.55M | 6.90% | 2.55M | — | 2.55M | — | IN | Israel | 2016-12-08 | ↗ |
| 13 | Millennium Partners, L.P. | 2.53M | 9.99% | 2.53M | — | 2.53M | — | PN | Cayman Islands | 2001-12-21 | ↗ |
| 14 | Merrill Lynch & Co., Inc. | 2.46M | 15.90% | — | 2.46M | — | 2.46M | HC, CO | Delaware | 1997-02-11 | ↗ |
| 15 | Merrill Lynch Group, Inc. | 2.46M | 15.90% | — | 2.46M | — | 2.46M | HC, CO | Delaware | 1997-02-11 | ↗ |
| 16 | Merrill Lynch Growth Fund for Investment & Retirement | 2.46M | 15.90% | — | 2.46M | — | 2.46M | IV, CO | Massachusetts | 1997-02-11 | ↗ |
| 17 | ICS Opportunities, Ltd. | 2.40M | 10.00% | — | 2.40M | — | 2.40M | CO | Delaware | 2011-12-23 | ↗ |
| 18 | Israel A. Englander | 2.40M | 10.00% | — | 2.40M | — | 2.40M | IN | Delaware | 2011-12-23 | ↗ |
| 19 | Millennium International Management GP LLC | 2.40M | 10.00% | — | 2.40M | — | 2.40M | OO | Delaware | 2011-12-23 | ↗ |
| 20 | Millennium International Management LP | 2.40M | 10.00% | — | 2.40M | — | 2.40M | PN | Delaware | 2011-12-23 | ↗ |
| 21 | Millennium Management LLC | 2.40M | 10.00% | — | 2.40M | — | 2.40M | OO | Delaware | 2011-12-23 | ↗ |
| 22 | Joseph Mona | 2.40M | 5.69% | 2.40M | — | 2.40M | — | IN | USA | 2019-10-21 | ↗ |
| 23 | Alpha Capital Anstalt | 1.69M | 7.57% | 1.69M | — | 1.69M | — | CO | Liechtenstein | 2011-12-23 | ↗ |
| 24 | 52-0556948 | 960.0K | 5.30% | 160.0K | — | 960.0K | — | IA | MARYLAND | 1998-02-09 | ↗ |
| 25 | Scudder, Stevens & Clark, Inc. | 921.0K | 11.00% | 200.9K | 462.9K | 921.0K | — | IA | Delaware | 1997-02-10 | ↗ |
| 26 | Armistice Capital, LLC | 799.2K | 9.99% | — | 799.2K | — | — | IA, OO | Delaware | 2023-02-14 | ↗ |
| 27 | Steven Boyd | 799.2K | 9.99% | — | 799.2K | — | — | HC, IN | United States of America | 2023-02-14 | ↗ |
| 28 | Chasing Value Asset Management Inc. (TIN: 27-4574274) | 610.7K | 8.60% | 207.0K | — | 610.7K | — | IA | California | 2021-01-20 | ↗ |
| 29 | Armistice Capital Master Fund Ltd. | 125.0K | 2.80% | — | 125.0K | — | 125.0K | CO | Delaware | 2019-01-25 | ↗ |
| 30 | Gabelli Associates Limited | 15.0K | 0.19% | 1.95M | — | 1.95M | — | CO | United States | 2016-12-08 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
28
-47 vs prev Q
New positions
9
Closed positions
53
Increased
17
Reduced
2
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 3.33M +986.2K (+42.1%) | 6.66M -488.4K (-6.8%) | 6.92% +0.500 pp | 0.00% +0.000 pp | USD2.57 -22.2% | 30 qtrs — |
| 2 | CIBC PRIVATE WEALTH GROUP, LLC | 1.48M +26.0K (+1.8%) | 2.96M -1.5M (-33.3%) | 3.08% -0.908 pp | 0.01% -0.003 pp | USD2.81 -28.8% | 3 qtrs — |
| 3 | BLACKROCK, INC. | 868.7K +378.5K (+77.2%) | 1.74M +242.2K (+16.2%) | 1.81% +0.463 pp | 0.00% +0.000 pp | USD2.02 -1.0% | 6 qtrs — |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 762.0K +268.6K (+54.4%) | 1.52M +18.9K (+1.3%) | 1.58% +0.232 pp | 0.00% +0.000 pp | USD2.17 -7.8% | 29 qtrs — |
| 5 | DNB ASSET MANAGEMENT AS | 677.5K +433.9K (+178.1%) | 1.35M +611.9K (+82.4%) | 1.41% +0.741 pp | 0.00% +0.002 pp | USD2.06 -2.9% | 4 qtrs — |
| 6 | UBS GROUP AG | 445.1K +242.3K (+119.4%) | 890.3K +271.6K (+43.9%) | 0.93% +0.370 pp | 0.00% +0.000 pp | USD2.33 -14.2% | 15 qtrs — |
| 7 | STIFEL FINANCIAL CORP | 266.0K +108.5K (+68.9%) | 532.0K +51.6K (+10.7%) | 0.55% +0.121 pp | 0.00% +0.000 pp | USD2.55 -21.6% | 9 qtrs — |
| 8 | 683 CAPITAL MANAGEMENT, LLC | 256.0K +256.0K (+100.0%) | 512.1K +512.1K (+100.0%) | 0.53% +0.532 pp | 0.02% +0.022 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 9 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 218.7K -74.6K (-25.4%) | 437.4K -457.2K (-51.1%) | 0.45% -0.349 pp | 0.00% 0.000 pp | USD2.90 -31.0% | 4 qtrs — |
| 10 | STATE STREET CORP | 207.2K -1.3K (-0.6%) | 414.3K -221.5K (-34.8%) | 0.43% -0.141 pp | 0.00% +0.000 pp | USD2.83 -29.3% | 19 qtrs — |
| 11 | ALPHACENTRIC ADVISORS LLC | 200.0K +200.0K (+100.0%) | 400.0K +400.0K (+100.0%) | 0.42% +0.416 pp | 0.40% +0.399 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 12 | JANE STREET GROUP, LLC | 197.4K +3.8K (+1.9%) | 394.8K -195.8K (-33.2%) | 0.41% -0.120 pp | 0.00% +0.000 pp | USD3.03 -34.0% | 4 qtrs — |
| 13 | OMERS ADMINISTRATION CORP | 146.0K +146.0K (+100.0%) | 292.0K +292.0K (+100.0%) | 0.30% +0.304 pp | 0.00% +0.002 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 14 | QUBE RESEARCH & TECHNOLOGIES LTD | 131.7K +131.7K (+100.0%) | 263.4K +263.4K (+100.0%) | 0.27% +0.274 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 15 | CITADEL ADVISORS LLC | 127.8K +112.2K (+719.2%) | 255.6K +208.0K (+437.2%) | 0.27% +0.223 pp | 0.00% +0.000 pp | USD2.02 -1.0% | 4 qtrs — |
| 16 | NORTHERN TRUST CORP | 114.2K +34.1K (+42.6%) | 228.4K -15.9K (-6.5%) | 0.24% +0.018 pp | 0.00% +0.000 pp | USD2.17 -7.8% | 24 qtrs — |
| 17 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111.0K +111.0K (+100.0%) | 222.0K +222.0K (+100.0%) | 0.23% +0.231 pp | 0.00% +0.005 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 18 | SIMPLEX TRADING, LLC | 71.2K +51.1K (+254.6%) | 142.5K +81.5K (+133.5%) | 0.15% +0.093 pp | 0.00% +0.000 pp | USD2.30 -13.0% | 2 qtrs — |
| 19 | MORGAN STANLEY | 69.0K +61.1K (+779.4%) | 137.9K +114.0K (+476.7%) | 0.14% +0.122 pp | 0.00% +0.000 pp | USD2.05 -2.4% | 30 qtrs — |
| 20 | TWO SIGMA INVESTMENTS, LP | 61.1K -1.3K (-2.1%) | 122.2K -68.1K (-35.8%) | 0.13% -0.044 pp | 0.00% 0.000 pp | USD1.52 +31.6% | 4 qtrs — |
| 21 | BARCLAYS PLC | 59.4K +59.4K (+5,937,600.0%) | 118.8K +118.8K (+11,875,300.0%) | 0.12% +0.124 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 9 qtrs — |
| 22 | VIRTU FINANCIAL LLC | 58.7K +58.7K (+100.0%) | 117.0K +117.0K (+100.0%) | 0.12% +0.122 pp | 0.00% +0.005 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 23 | LPL FINANCIAL LLC | 47.9K -2.0K (-4.0%) | 95.9K -56.3K (-37.0%) | 0.10% -0.037 pp | 0.00% +0.000 pp | USD2.58 -22.5% | 3 qtrs — |
| 24 | MILLENNIUM MANAGEMENT LLC | 46.8K -38.0K (-44.8%) | 93.6K -165.0K (-63.8%) | 0.10% -0.135 pp | 0.00% 0.000 pp | USD3.05 -34.4% | 2 qtrs — |
| 25 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 41.1K +41.1K (+100.0%) | 82.2K +82.2K (+100.0%) | 0.09% +0.086 pp | 0.00% +0.003 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 26 | HILLTOP HOLDINGS INC. | 35.8K +— (+0.0%) | 71.5K -37.6K (-34.4%) | 0.07% -0.024 pp | 0.00% -0.002 pp | USD2.08 -3.8% | 11 qtrs — |
| 27 | ENVESTNET ASSET MANAGEMENT INC | 35.7K +3.4K (+10.5%) | 71.3K -27.1K (-27.5%) | 0.07% -0.014 pp | 0.00% +0.000 pp | USD2.95 -32.2% | 4 qtrs — |
| 28 | GOLDMAN SACHS GROUP INC | 34.5K +34.5K (+100.0%) | 68.9K +68.9K (+100.0%) | 0.07% +0.072 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 4 qtrs — |
| 29 | CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 32.6K +32.6K (+100.0%) | 65.2K +65.2K (+100.0%) | 0.07% +0.068 pp | 0.02% +0.016 pp | USD2.00 +0.0% | 4 qtrs — |
| 30 | XTX TOPCO LTD | 31.4K +31.4K (+100.0%) | 62.8K +62.8K (+100.0%) | 0.07% +0.065 pp | 0.00% +0.002 pp | USD2.00 +0.0% | 3 qtrs — |
| 31 | VONTOBEL HOLDING LTD. | 30.9K +— (+0.0%) | 61.7K -32.4K (-34.4%) | 0.06% -0.020 pp | 0.00% 0.000 pp | USD3.05 -34.4% | 2 qtrs — |
| 32 | CETERA INVESTMENT ADVISERS | 29.3K +8.2K (+38.8%) | 58.6K -5.8K (-9.0%) | 0.06% +0.003 pp | 0.00% +0.000 pp | USD2.76 -27.5% | 2 qtrs — |
| 33 | SCOTIA CAPITAL INC. | 26.5K +— (+0.0%) | 53.0K -27.8K (-34.4%) | 0.06% -0.018 pp | 0.00% 0.000 pp | USD1.53 +30.7% | 5 qtrs — |
| 34 | RENAISSANCE TECHNOLOGIES LLC | 24.6K +24.6K (+100.0%) | 49.1K +49.1K (+100.0%) | 0.05% +0.051 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 35 | SQUAREPOINT OPS LLC | 24.5K +12.4K (+102.6%) | 49.1K +12.1K (+32.8%) | 0.05% +0.018 pp | 0.00% +0.000 pp | USD2.52 -20.6% | 4 qtrs — |
| 36 | INVESCO LTD. | 24.5K +24.5K (+100.0%) | 49.0K +49.0K (+100.0%) | 0.05% +0.051 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 37 | BEACON CAPITAL MANAGEMENT, LLC | 22.0K +— (+0.0%) | 44.0K -23.1K (-34.4%) | 0.05% -0.015 pp | 0.01% -0.003 pp | USD2.72 -26.5% | 11 qtrs — |
| 38 | LAZARI CAPITAL MANAGEMENT, INC. | 21.3K +— (+0.0%) | 42.5K -22.3K (-34.4%) | 0.04% -0.014 pp | 0.01% -0.008 pp | USD2.52 -20.6% | 3 qtrs — |
| 39 | CAPTION MANAGEMENT, LLC | 20.0K +20.0K (+100.0%) | 40.0K +40.0K (+100.0%) | 0.04% +0.042 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 40 | MAN GROUP PLC | 17.4K +17.4K (+100.0%) | 34.8K +34.8K (+100.0%) | 0.04% +0.036 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 41 | QUANTBOT TECHNOLOGIES LP | 13.7K +13.7K (+100.0%) | 27.4K +27.4K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.001 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 42 | STONEX GROUP INC. | 12.0K +12.0K (+100.0%) | 24.1K +24.1K (+100.0%) | 0.03% +0.025 pp | 0.00% +0.001 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 43 | TWO SIGMA SECURITIES, LLC | 10.6K -19.5K (-64.8%) | 21.2K -70.7K (-76.9%) | 0.02% -0.061 pp | 0.00% -0.011 pp | USD3.05 -34.4% | 9 qtrs — |
| 44 | LEE DANNER & BASS INC | 10.3K -386.0 (-3.6%) | 20.5K -11.9K (-36.8%) | 0.02% -0.008 pp | 0.00% -0.001 pp | USD1.51 +32.5% | 5 qtrs — |
| 45 | CORNERSTONE ADVISORY, LLC | 10.0K +— (+0.0%) | 20.0K -10.5K (-34.4%) | 0.02% -0.007 pp | 0.00% -0.001 pp | USD3.05 -34.4% | 2 qtrs — |
| 46 | U.S. CAPITAL WEALTH ADVISORS, LLC | 10.0K -1.3K (-11.5%) | 20.0K -14.5K (-42.0%) | 0.02% -0.010 pp | 0.00% 0.000 pp | USD2.58 -22.5% | 3 qtrs — |
| 47 | WELLS FARGO & COMPANY/MN | 8.7K -1.6K (-15.8%) | 17.5K -14.2K (-44.8%) | 0.02% -0.010 pp | 0.00% +0.000 pp | USD2.21 -9.5% | 30 qtrs — |
| 48 | BFSG, LLC | 5.5K +— (+0.0%) | 11.0K -5.8K (-34.4%) | 0.01% -0.004 pp | 0.00% -0.001 pp | USD1.07 +86.9% | 8 qtrs — |
| 49 | CITIGROUP INC | 4.9K +4.9K (+100.0%) | 9.7K +9.7K (+100.0%) | 0.01% +0.010 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 3 qtrs — |
| 50 | BANK OF AMERICA CORP /DE/ | 4.2K -18.9K (-81.7%) | 8.5K -62.1K (-88.0%) | 0.01% -0.055 pp | 0.00% +0.000 pp | USD2.89 -30.8% | 13 qtrs — |
| 51 | ADVISOR GROUP HOLDINGS, INC. | 3.0K -10.3K (-77.4%) | 6.0K -44.7K (-88.1%) | 0.01% -0.030 pp | 0.00% 0.000 pp | USD2.86 -30.1% | 24 qtrs — |
| 52 | SBI SECURITIES CO., LTD. | 2.6K -940.0 (-26.3%) | 5.3K -5.6K (-51.7%) | 0.01% -0.004 pp | 0.00% 0.000 pp | USD1.31 +52.7% | 5 qtrs — |
| 53 | CWM, LLC | 2.7K +— (+0.0%) | 5.0K -3.0K (-37.5%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD3.05 -34.4% | 2 qtrs — |
| 54 | ROYAL BANK OF CANADA | 1.9K +— (+0.0%) | 4.0K -2.0K (-33.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD1.33 +50.4% | 8 qtrs — |
| 55 | AVION WEALTH | 1.5K +500.0 (+50.0%) | 3.0K +— (+0.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.70 -25.9% | 2 qtrs — |
| 56 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 1.3K +— (+0.0%) | 2.6K -1.4K (-34.4%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD5.70 -64.9% | 27 qtrs — |
| 57 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.1K -35.1K (-97.1%) | 2.1K -108.0K (-98.1%) | 0.00% -0.097 pp | 0.00% -0.003 pp | USD2.98 -32.9% | 9 qtrs — |
| 58 | SRS CAPITAL ADVISORS, INC. | 688.00 +382.0 (+124.8%) | 1.4K +442.0 (+47.3%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.47 -19.0% | 2 qtrs — |
| 59 | EVERSOURCE WEALTH ADVISORS, LLC | 357.00 +— (+0.0%) | 714.00 -375.0 (-34.4%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD1.51 +32.5% | 4 qtrs — |
| 60 | CLEARSTEAD ADVISORS, LLC | 275.00 +275.0 (+100.0%) | 550.00 +550.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 61 | ALLWORTH FINANCIAL LP | 130.00 +— (+0.0%) | 260.00 -137.0 (-34.5%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD2.52 -20.6% | 3 qtrs — |
| 62 | — | 50.00 +50.0 (+100.0%) | 100.00 +100.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 63 | SIGNATUREFD, LLC | 18.00 +— (+0.0%) | 36.00 -19.0 (-34.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -33.3% | 2 qtrs — |
| 64 | JONES FINANCIAL COMPANIES LLLP | 1.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +100.0% | 5 qtrs — |
| 65 | HARBOUR INVESTMENTS, INC. | 1.00 +1.0 (+100.0%) | 2.00 +2.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 1 qtrs NEW |
| 66 | FMR LLC | 1.00 -310.0 (-99.7%) | 2.00 -946.0 (-99.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.00 -33.3% | 7 qtrs — |
| 67 | FINANCIALLY SPEAKING INC | 1.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +100.0% | 5 qtrs — |
| 68 | FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 1.00 -1.4K (-99.9%) | 2.00 -4.3K (-100.0%) | 0.00% -0.004 pp | 0.00% +0.000 pp | USD3.00 -33.3% | 4 qtrs — |
| 69 | EVELYN PARTNERS INVESTMENT MANAGEMENT SERVICES LTD | 1.00 +— (+0.0%) | 2.00 -1.0 (-33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.00 +100.0% | 5 qtrs — |
| 70 | ATLANTIC UNION BANKSHARES CORP | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.00 -33.3% | 2 qtrs — |
| 71 | WOLFF WIESE MAGANA LLC | 1.00 +— (+0.0%) | 2.00 -2.0 (-50.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.00 +0.0% | 3 qtrs — |
| 72 | SLT HOLDINGS LLC | — -12.5K (-100.0%) | — -38.1K (-100.0%) | 0.00% -0.034 pp | 0.00% -0.025 pp | USD— | 2 qtrs SOLD |
| 73 | OXFORD ASSET MANAGEMENT LLP | — -17.7K (-100.0%) | — -54.0K (-100.0%) | 0.00% -0.049 pp | 0.00% -0.018 pp | USD— | 2 qtrs SOLD |
| 74 | FOUNDATIONS INVESTMENT ADVISORS, LLC | — -12.5K (-100.0%) | — -38.1K (-100.0%) | 0.00% -0.034 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 75 | ZACKS INVESTMENT MANAGEMENT | — -10.7K (-100.0%) | — -32.6K (-100.0%) | 0.00% -0.029 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 76 | AMERITAS ADVISORY SERVICES, LLC | — -1.2K (-100.0%) | — -3.6K (-100.0%) | 0.00% -0.003 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 77 | GROUP ONE TRADING, L.P. | — -18.6K (-100.0%) | — -56.8K (-100.0%) | 0.00% -0.051 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 78 | WEALTHSPIRE ADVISORS, LLC | — -1.0 (-100.0%) | — -3.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 79 | NATIONAL BANK OF CANADA /FI/ | — -13.5K (-100.0%) | — -41.2K (-100.0%) | 0.00% -0.037 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 80 | WEXFORD CAPITAL LP | — -16.3K (-100.0%) | — -49.6K (-100.0%) | 0.00% -0.045 pp | 0.00% -0.007 pp | USD— | 2 qtrs SOLD |
| 81 | HILLTOP NATIONAL BANK | — -1.0 (-100.0%) | — -3.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 3 qtrs SOLD |
| 82 | HEIGHTS CAPITAL MANAGEMENT, INC | — -883.1K (-100.0%) | — -2.7M (-100.0%) | 0.00% -2.420 pp | 0.00% -0.739 pp | USD— | 2 qtrs SOLD |
| 83 | EAM INVESTORS, LLC | — -207.3K (-100.0%) | — -632.3K (-100.0%) | 0.00% -0.568 pp | 0.00% -0.073 pp | USD— | 2 qtrs SOLD |
| 84 | EHP FUNDS INC. | — -25.4K (-100.0%) | — -77.6K (-100.0%) | 0.00% -0.070 pp | 0.00% -0.069 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 14 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Invesco NASDAQ Future Gen 200 ETF QQQS | 0.46% | 102.1K | 0.20% |
| 2 | iShares Micro-Cap ETF IWC | 0.03% | 436.4K | 0.60% |
| 3 | Avantis U.S. Small Cap Equity ETF AVSC | 0.01% | 176.4K | 0.25% |
| 4 | Vanguard Extended Market ETF VXF | 0.00% | 1.47M | 0.05% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.8K | 0.17% |
| 6 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 9.1K | 0.03% |
| 7 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 24.9K | 0.17% |
| 8 | Vanguard Total Stock Market ETF VTI | 0.00% | 4.26M | 0.03% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 9.3K | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 5.1K | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
6
Sells
0
Shares acquired
60.0K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+60,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Wilson David James | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.37 | 23.7K | 10,000 | D | ↗ |
| 2026-04-01 | Wenderow Tal Baruch | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.37 | 23.7K | 10,000 | D | ↗ |
| 2026-04-01 | Stockburger Aileen Ptucha | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.37 | 23.7K | 10,000 | D | ↗ |
| 2026-04-01 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.37 | 23.7K | 10,000 | D | ↗ |
| 2026-04-01 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.37 | 23.7K | 10,000 | D | ↗ |
| 2026-04-01 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 2.37 | 23.7K | 10,000 | D | ↗ |
| 2026-02-18 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 105,000 | 2.10 | 220.5K | 105,000 | D | ↗ |
| 2026-02-18 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 105,000 | 2.10 | 220.5K | 105,000 | D | ↗ |
| 2026-02-18 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 480,000 | 2.10 | 1.01M | 480,000 | D | ↗ |
| 2026-02-18 | Diaz-Cartelle Juan | Officer | A-Award | A | Stock Option (Right to Buy) | 105,000 | 2.10 | 220.5K | 105,000 | D | ↗ |
| 2025-02-05 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 48,125 | 2.04 | 98.2K | 48,125 | D | ↗ |
| 2025-02-05 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 43,750 | 2.04 | 89.3K | 43,750 | D | ↗ |
| 2025-02-05 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 228,000 | 2.04 | 465.1K | 228,000 | D | ↗ |
| 2025-02-05 | Diaz-Cartelle Juan | Officer | A-Award | A | Stock Option (Right to Buy) | 42,000 | 2.04 | 85.7K | 42,000 | D | ↗ |
| 2025-01-28 | Wilson David James | Director | A-Award | A | Stock Option (Right to Buy) | 20,000 | 1.93 | 38.6K | 20,000 | D | ↗ |
| 2025-01-28 | Wenderow Tal Baruch | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.93 | 19.3K | 10,000 | D | ↗ |
| 2025-01-28 | Stockburger Aileen Ptucha | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.93 | 19.3K | 10,000 | D | ↗ |
| 2025-01-28 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.93 | 19.3K | 10,000 | D | ↗ |
| 2025-01-28 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.93 | 19.3K | 10,000 | D | ↗ |
| 2025-01-28 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 10,000 | 1.93 | 19.3K | 10,000 | D | ↗ |
| 2024-12-17 | Wilson David James | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-02-26 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 4,375 | 1.25 | 5.5K | 4,375 | D | ↗ |
| 2024-02-26 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 8,750 | 1.25 | 10.9K | 8,750 | D | ↗ |
| 2024-02-26 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 12,000 | 1.25 | 15.0K | 12,000 | D | ↗ |
| 2024-02-26 | Diaz-Cartelle Juan | Officer | A-Award | A | Stock Option (Right to Buy) | 10,500 | 1.25 | 13.1K | 10,500 | D | ↗ |
| 2024-02-22 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 1.27 | 22.2K | 17,500 | — | ↗ |
| 2024-02-22 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 1.27 | 22.2K | 17,500 | — | ↗ |
| 2024-02-22 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 1.27 | 101.5K | 80,000 | — | ↗ |
| 2024-02-22 | Diaz-Cartelle Juan | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 1.27 | 22.2K | 17,500 | — | ↗ |
| 2023-12-01 | Diaz-Cartelle Juan | Officer | — | D | Stock Option (Right to Buy) | 25,000 | 1.29 | 32.3K | 0 | — | ↗ |
| 2023-11-02 | Wenderow Tal Baruch | Director | A-Award | A | Stock Option (Right to Buy) | 74,218 | 1.28 | 95.0K | 74,218 | — | ↗ |
| 2023-11-02 | Stockburger Aileen Ptucha | Director | A-Award | A | Stock Option (Right to Buy) | 74,218 | 1.28 | 95.0K | 74,218 | — | ↗ |
| 2023-11-02 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 74,218 | 1.28 | 95.0K | 74,218 | — | ↗ |
| 2023-11-02 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 74,218 | 1.28 | 95.0K | 74,218 | — | ↗ |
| 2023-11-02 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 74,218 | 1.28 | 95.0K | 74,218 | — | ↗ |
| 2023-11-02 | Bornstein Yoseph | Director | A-Award | A | Stock Option (Right to Buy) | 74,218 | 1.28 | 95.0K | 74,218 | — | ↗ |
| 2023-08-01 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 2.43 | 42.5K | 17,500 | — | ↗ |
| 2023-08-01 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 2.43 | 42.5K | 17,500 | — | ↗ |
| 2023-08-01 | Morag Eyal | Officer | A-Award | A | Stock Option (Right to Buy) | 17,500 | 2.43 | 42.5K | 17,500 | — | ↗ |
| 2023-08-01 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 2.43 | 194.4K | 80,000 | — | ↗ |
| 2023-01-17 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 35,000 | 0.00 | — | 35,000 | — | ↗ |
| 2023-01-17 | Morag Eyal | Officer | A-Award | A | Stock Option (Right to Buy) | 35,000 | 0.00 | — | 35,000 | — | ↗ |
| 2022-12-21 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 13,000 | 0.00 | — | 13,000 | — | ↗ |
| 2022-12-21 | Gadot Harel | Officer | A-Award | A | Stock Option (Right to Buy) | 160,000 | 0.00 | — | 160,000 | — | ↗ |
| 2022-09-21 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 16,637 | 5.71 | 95.0K | 16,637 | — | ↗ |
| 2022-07-18 | Vaknin Rachel | Officer | A-Award | A | Stock Option (Right to Buy) | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2022-04-01 | Vaknin Rachel | Officer | — | D | Stock Option (Right to Buy) | 20,000 | 6.48 | 129.6K | 0 | — | ↗ |
| 2022-01-26 | Sharon Simon | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 6.48 | 162.0K | 25,000 | — | ↗ |
| 2022-01-26 | Morag Eyal | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 6.48 | 162.0K | 25,000 | — | ↗ |
| 2022-01-26 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 100,000 | 6.48 | 648.0K | 100,000 | — | ↗ |
| 2021-09-29 | Wenderow Tal Baruch | Director | A-Award | A | Stock Option (Right to Buy) | 13,571 | 7.00 | 95.0K | 13,571 | — | ↗ |
| 2021-09-29 | Stockburger Aileen Ptucha | Director | A-Award | A | Stock Option (Right to Buy) | 13,571 | 7.00 | 95.0K | 13,571 | — | ↗ |
| 2021-09-29 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 13,571 | 7.00 | 95.0K | 13,571 | — | ↗ |
| 2021-09-29 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 13,571 | 7.00 | 95.0K | 13,571 | — | ↗ |
| 2021-09-29 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 13,571 | 7.00 | 95.0K | 13,571 | — | ↗ |
| 2021-09-29 | Bornstein Yoseph | Director | A-Award | A | Stock Option (Right to Buy) | 13,571 | 7.00 | 95.0K | 13,571 | — | ↗ |
| 2021-04-07 | Sharon Simon | Officer | — | D | Stock Option (Right to Buy) | 10,000 | 9.00 | 90.0K | 0 | — | ↗ |
| 2021-02-01 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 190,000 | 8.48 | 1.61M | 190,000 | — | ↗ |
| 2020-11-05 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 7.22 | 20.0K | 2,771 | — | ↗ |
| 2020-11-05 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 7.22 | 20.0K | 2,771 | — | ↗ |
| 2020-11-05 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 7.22 | 20.0K | 2,771 | — | ↗ |
| 2020-11-05 | Bornstein Yoseph | Director | A-Award | A | Stock Option (Right to Buy) | 2,771 | 7.22 | 20.0K | 2,771 | — | ↗ |
| 2020-10-19 | Bornstein Yoseph | Director | S-Sale | D | Common Stock | 4,881 | 7.94 | 38.7K | 242,028 | — | ↗ |
| 2020-10-12 | Bornstein Yoseph | Director | S-Sale | D | Common Stock | 20,000 | 7.84 | 156.9K | 246,909 | — | ↗ |
| 2020-10-05 | Bornstein Yoseph | Director | S-Sale | D | Common Stock | 20,000 | 7.84 | 156.9K | 246,909 | — | ↗ |
| 2020-08-17 | Bornstein Yoseph | Director | S-Sale | D | Common Stock | 119 | 11.91 | 1.4K | 286,909 | — | ↗ |
| 2020-08-14 | Wenderow Tal Baruch | Director | A-Award | A | Stock Option (Right to Buy) | 4,902 | 8.16 | 40.0K | 4,902 | — | ↗ |
| 2020-08-01 | Wenderow Tal Baruch | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-07-14 | Stockburger Aileen Ptucha | Director | A-Award | A | Stock Option (Right to Buy) | 6,493 | 6.16 | 40.0K | 6,493 | — | ↗ |
| 2020-07-14 | Morag Eyal | Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 6.16 | 154.0K | 25,000 | — | ↗ |
| 2020-05-01 | Morag Eyal | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-04-01 | Stockburger Aileen Ptucha | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-02-25 | Gadot Harel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 166,666 | 9.64 | 1.61M | 166,666 | — | ↗ |
| 2019-12-23 | Gadot Harel | Director / Officer | S-Sale | D | Common Stock, par value $0.01 per share | 40,000 | 10.00 | 400.0K | 136,847 | — | ↗ |
| 2019-10-23 | Waizer Yoav Zvi | Director | A-Award | A | Stock Option (Right to Buy) | 3,952 | 5.06 | 20.0K | 3,952 | — | ↗ |
| 2019-10-23 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 3,952 | 5.06 | 20.0K | 3,952 | — | ↗ |
| 2019-10-23 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 3,952 | 5.06 | 20.0K | 3,952 | — | ↗ |
| 2019-10-23 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 3,952 | 5.06 | 20.0K | 3,952 | — | ↗ |
| 2019-10-23 | Bornstein Yoseph | Director | A-Award | A | Stock Option (Right to Buy) | 3,952 | 5.06 | 20.0K | 3,952 | — | ↗ |
| 2019-01-21 | Waizer Yoav Zvi | Director | A-Award | A | Stock Option (Right to Buy) | 2,326 | 8.60 | 20.0K | 2,326 | — | ↗ |
| 2019-01-21 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 2,326 | 8.60 | 20.0K | 2,326 | — | ↗ |
| 2019-01-21 | Laxminarain Prattipati | Director | A-Award | A | Stock Option (Right to Buy) | 2,326 | 8.60 | 20.0K | 2,326 | — | ↗ |
| 2019-01-21 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 2,326 | 8.60 | 20.0K | 2,326 | — | ↗ |
| 2019-01-21 | Bornstein Yoseph | Director | A-Award | A | Stock Option (Right to Buy) | 2,326 | 8.60 | 20.0K | 2,326 | — | ↗ |
| 2018-12-31 | Mona Joseph | 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2018-11-16 | Mona Joseph | 10% Owner | — | D | Microbot Medical Common Stock | 0 | 0.00 | — | 300,320 | — | ↗ |
| 2018-01-09 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 35,000 | 1.06 | 37.2K | 4,530,409 | — | ↗ |
| 2018-01-03 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 2,868 | 1.01 | 2.9K | 4,565,409 | — | ↗ |
| 2018-01-02 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 42,132 | 1.01 | 42.5K | 4,568,277 | — | ↗ |
| 2017-12-28 | Naim David Ben | Officer | A-Award | A | Stock Option (Right to Buy) | 75,000 | 1.02 | 76.5K | 75,000 | — | ↗ |
| 2017-12-27 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 14,257 | 1.02 | 14.6K | 4,610,409 | — | ↗ |
| 2017-12-26 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 30,743 | 1.02 | 31.4K | 4,624,666 | — | ↗ |
| 2017-12-20 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 12,933 | 1.03 | 13.3K | 4,655,409 | — | ↗ |
| 2017-12-19 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 32,067 | 1.03 | 33.0K | 4,655,409 | — | ↗ |
| 2017-12-13 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 841 | 1.02 | 857.82 | 4,700,409 | — | ↗ |
| 2017-12-12 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 44,159 | 1.04 | 45.8K | 4,701,250 | — | ↗ |
| 2017-12-06 | Waizer Yoav Zvi | Director | A-Award | A | Stock Option (Right to Buy) | 38,095 | 1.05 | 40.0K | 38,095 | — | ↗ |
| 2017-12-06 | Madden Martin J. | Director | A-Award | A | Stock Option (Right to Buy) | 38,095 | 1.05 | 40.0K | 38,095 | — | ↗ |
| 2017-12-06 | Laxminarain Prattipati | Director | — | D | Stock Option (Right to Buy) | 38,095 | 1.05 | 40.0K | 0 | — | ↗ |
| 2017-12-06 | Burell Scott R | Director | A-Award | A | Stock Option (Right to Buy) | 38,095 | 1.05 | 40.0K | 38,095 | — | ↗ |
| 2017-12-06 | Bornstein Yoseph | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 38,095 | 1.05 | 40.0K | 38,095 | — | ↗ |
| 2017-12-05 | Waizer Yoav Zvi | Director | S-Sale | D | Common Stock | 10,000 | 1.08 | 10.8K | 0 | — | ↗ |
| 2017-12-05 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 29,625 | 1.08 | 32.1K | 4,760,784 | — | ↗ |
| 2017-12-04 | Waizer Yoav Zvi | Director | P-Purchase | A | Common Stock | 10,000 | 1.10 | 11.0K | 10,000 | — | ↗ |
| 2017-11-28 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 45,000 | 1.07 | 48.3K | 4,790,409 | — | ↗ |
| 2017-11-21 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 45,000 | 1.21 | 54.5K | 4,835,409 | — | ↗ |
| 2017-10-24 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.13 | 28.3K | 4,880,399 | — | ↗ |
| 2017-10-17 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.16 | 28.9K | 4,930,399 | — | ↗ |
| 2017-10-15 | Himelfarb Yehezkel | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 1,087,627 | 1.29 | 1.40M | 1,087,627 | — | ↗ |
| 2017-10-10 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.39 | 34.7K | 5,020,409 | — | ↗ |
| 2017-10-09 | Shoham Moshe | Director | S-Sale | D | Common Stock | 16,600 | 1.50 | 24.9K | 1,558,390 | — | ↗ |
| 2017-10-05 | Shoham Moshe | Director | S-Sale | D | Common Stock | 17,100 | 1.50 | 25.7K | 1,558,390 | — | ↗ |
| 2017-10-05 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 22,000 | 1.49 | 32.8K | 5,070,409 | — | ↗ |
| 2017-10-04 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 3,000 | 1.48 | 4.4K | 5,092,409 | — | ↗ |
| 2017-10-03 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.19 | 29.7K | 5,092,409 | — | ↗ |
| 2017-09-26 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.23 | 30.7K | 5,145,409 | — | ↗ |
| 2017-09-19 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.18 | 29.4K | 5,195,409 | — | ↗ |
| 2017-09-15 | Shoham Moshe | Director | S-Sale | D | Common Stock | 9,001 | 1.30 | 11.7K | 1,592,090 | — | ↗ |
| 2017-09-14 | Gadot Harel | Director / Officer / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 1,336,522 | 1.05 | 1.40M | 1,336,522 | — | ↗ |
| 2017-09-12 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 20,000 | 1.12 | 22.4K | 5,204,799 | — | ↗ |
| 2017-09-06 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 25,000 | 1.00 | 25.0K | 5,245,409 | — | ↗ |
| 2017-08-30 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 5,000 | 1.07 | 5.4K | 5,275,409 | — | ↗ |
| 2017-08-25 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 15,000 | 1.08 | 16.2K | 5,280,409 | — | ↗ |
| 2017-08-24 | Bornstein Yoseph | Director / 10% Owner | S-Sale | D | Common Stock | 10,000 | 1.03 | 10.3K | 5,295,409 | — | ↗ |
| 2017-06-16 | Lewkowicz Leon | 10% Owner | S-Sale | D | Common Stock | 71,224 | 1.67 | 118.9K | 3,078,214 | — | ↗ |
| 2017-01-06 | Madden Martin J. | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-12-05 | Himelfarb Yehezkel | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Waizer Yoav Zvi | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Solomon Mayer | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Shoham Moshe | Director | — | D | Stock Option (Right to Buy) | 708,141 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Naim David Ben | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Lewkowicz Leon | 10% Owner | — | D | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 3,149,438 | — | ↗ |
| 2016-11-28 | Gadot Harel | Director / Officer / 10% Owner | — | I | Stock Option (Right to Buy) | 1,167,960 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Burell Scott R | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2016-11-28 | Bornstein Yoseph | Director / 10% Owner | — | I | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 5,305,409 | — | ↗ |
| 2016-11-28 | Berkson Avram | 10% Owner | — | D | Common Stock, par value $0.01 per share | 0 | 0.00 | — | 4,307,003 | — | ↗ |
| 2016-11-28 | ALPHA CAPITAL ANSTALT | 10% Owner | J-Other | A | Common Stock | 9,753,549 | 0.00 | — | 9,753,549 | — | ↗ |
| 2016-06-17 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 5,834 | 2.92 | 17.0K | 42,273 | — | ↗ |
| 2016-05-24 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 2,084 | 2.92 | 6.1K | 27,308 | — | ↗ |
| 2016-04-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 48,077 | 0.00 | — | 558,288 | — | ↗ |
| 2016-03-15 | SCHIFFMAN GREGORY T | Officer | A-Award | A | Common Stock | 720,000 | 0.00 | — | 1,599,717 | — | ↗ |
| 2016-03-15 | Massey Ian J | Officer | A-Award | A | Common Stock | 378,460 | 0.00 | — | 2,378,460 | — | ↗ |
| 2016-03-14 | SCHIFFMAN GREGORY T | Officer | A-Award | A | Series B Warrants (right to buy) | 124,500 | 0.42 | 52.3K | 207,500 | — | ↗ |
| 2016-01-27 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 14,228 | 0.35 | 5.0K | 507,273 | — | ↗ |
| 2016-01-27 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 4,378 | 0.35 | 1.5K | 352,695 | — | ↗ |
| 2016-01-18 | Massey Ian J | Officer | A-Award | A | Common Stock | 1,250,000 | 0.00 | — | 2,000,000 | — | ↗ |
| 2016-01-08 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 35,024 | 0.38 | 13.3K | 521,501 | — | ↗ |
| 2016-01-08 | SCHIFFMAN GREGORY T | Officer | F-InKind | D | Common Stock | 25,976 | 0.38 | 9.9K | 713,717 | — | ↗ |
| 2016-01-08 | MCGLYNN MARTIN M | Director / Officer | F-InKind | A | Common Stock | 236,736 | 0.38 | 90.0K | 2,230,297 | — | ↗ |
| 2016-01-08 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 28,457 | 0.38 | 10.8K | 357,073 | — | ↗ |
| 2016-01-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 146,342 | 0.00 | — | 480,449 | — | ↗ |
| 2016-01-01 | Trounson Alan O | Director | A-Award | A | Common Stock | 146,342 | 0.00 | — | 354,595 | — | ↗ |
| 2016-01-01 | SCHWARTZ JOHN J | Director | A-Award | A | Common Stock | 146,342 | 0.00 | — | 334,673 | — | ↗ |
| 2016-01-01 | SCHIFFMAN GREGORY T | Officer | F-InKind | D | Common Stock | 38,307 | 0.42 | 16.1K | 739,693 | — | ↗ |
| 2016-01-01 | LEVY RICARDO B | Director | A-Award | A | Common Stock | 146,342 | 0.00 | — | 260,033 | — | ↗ |
| 2016-01-01 | GREER R SCOTT | Director | A-Award | A | Common Stock | 146,342 | 0.00 | — | 290,183 | — | ↗ |
| 2016-01-01 | BJERKHOLT ERIC | Director | A-Award | A | Common Stock | 146,342 | 0.00 | — | 273,759 | — | ↗ |
| 2015-12-29 | Stratton Kenneth Blair | Officer | S-Sale | D | Common Stock | 104,549 | 0.45 | 47.2K | 556,525 | — | ↗ |
| 2015-10-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 31,250 | 0.00 | — | 334,107 | — | ↗ |
| 2015-07-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 23,149 | 0.00 | — | 302,857 | — | ↗ |
| 2015-05-26 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 26,306 | 0.68 | 17.9K | 661,074 | — | ↗ |
| 2015-05-26 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 9,170 | 0.68 | 6.2K | 385,530 | — | ↗ |
| 2015-04-30 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 12,255 | 0.00 | — | 279,708 | — | ↗ |
| 2015-03-23 | Massey Ian J | Officer | A-Award | A | Common Stock | 750,000 | 0.00 | — | 750,000 | — | ↗ |
| 2015-01-27 | TSUKAMOTO ANN | Officer | F-InKind | D | Common Stock | 20,995 | 1.07 | 22.5K | 706,511 | — | ↗ |
| 2015-01-27 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 12,169 | 1.07 | 13.0K | 687,380 | — | ↗ |
| 2015-01-27 | MCGLYNN MARTIN M | Director / Officer | F-InKind | A | Common Stock | 50,858 | 1.07 | 54.4K | 2,642,033 | — | ↗ |
| 2015-01-27 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 4,388 | 1.07 | 4.7K | 394,700 | — | ↗ |
| 2015-01-08 | TSUKAMOTO ANN | Officer | A-Award | A | Common Stock | 250,000 | 0.00 | — | 627,506 | — | ↗ |
| 2015-01-08 | Stratton Kenneth Blair | Officer | A-Award | A | Common Stock | 240,000 | 0.00 | — | 619,549 | — | ↗ |
| 2015-01-08 | SCHIFFMAN GREGORY T | Officer | A-Award | A | Common Stock | 178,000 | 0.00 | — | 528,000 | — | ↗ |
| 2015-01-08 | MCGLYNN MARTIN M | Director / Officer | A-Award | A | Common Stock | 1,255,500 | 0.00 | — | 2,274,391 | — | ↗ |
| 2015-01-08 | KOSHY GEORGE | — | A-Award | A | Common Stock | 195,000 | 0.00 | — | 333,588 | — | ↗ |
| 2015-01-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 58,253 | 0.00 | — | 254,155 | — | ↗ |
| 2015-01-01 | Trounson Alan O | Director | A-Award | A | Common Stock | 58,253 | 0.00 | — | 208,253 | — | ↗ |
| 2015-01-01 | SCHWARTZ JOHN J | Director | A-Award | A | Common Stock | 58,253 | 0.00 | — | 188,331 | — | ↗ |
| 2015-01-01 | LEVY RICARDO B | Director | A-Award | A | Common Stock | 58,253 | 0.00 | — | 113,691 | — | ↗ |
| 2015-01-01 | GREER R SCOTT | Director | A-Award | A | Common Stock | 58,253 | 0.00 | — | 143,841 | — | ↗ |
| 2015-01-01 | BJERKHOLT ERIC | Director | A-Award | A | Common Stock | 58,253 | 0.00 | — | 127,417 | — | ↗ |
| 2014-07-07 | Trounson Alan O | Director | A-Award | A | Common Stock | 150,000 | 0.00 | — | 150,000 | — | ↗ |
| 2014-06-16 | MCGLYNN MARTIN M | Director / Officer | F-InKind | D | Common Stock | 99,883 | 1.52 | 151.8K | 1,018,891 | — | ↗ |
| 2014-06-06 | TSUKAMOTO ANN | Officer | F-InKind | D | Common Stock | 35,245 | 1.42 | 50.0K | 377,506 | — | ↗ |
| 2014-06-01 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 1,879 | 1.39 | 2.6K | 379,549 | — | ↗ |
| 2014-06-01 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 917 | 1.39 | 1.3K | 138,588 | — | ↗ |
| 2014-05-24 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 26,306 | 1.40 | 36.8K | 381,428 | — | ↗ |
| 2014-05-24 | KOSHY GEORGE | — | F-InKind | D | Common Stock | 9,170 | 1.40 | 12.8K | 139,505 | — | ↗ |
| 2014-04-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 9,329 | 0.00 | — | 212,466 | — | ↗ |
| 2014-01-27 | TSUKAMOTO ANN | Officer | F-InKind | D | Common Stock | 15,895 | 1.41 | 22.4K | 412,751 | — | ↗ |
| 2014-01-27 | Stratton Kenneth Blair | Officer | F-InKind | D | Common Stock | 11,921 | 1.41 | 16.8K | 407,734 | — | ↗ |
| 2014-01-27 | MCGLYNN MARTIN M | Director / Officer | F-InKind | D | Common Stock | 50,858 | 1.41 | 71.7K | 1,118,774 | — | ↗ |
| 2014-01-27 | CRAIG STEWART | Officer | F-InKind | D | Common Stock | 11,921 | 1.41 | 16.8K | 405,981 | — | ↗ |
| 2014-01-03 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 10,163 | 0.00 | — | 161,836 | — | ↗ |
| 2014-01-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 41,301 | 0.00 | — | 203,137 | — | ↗ |
| 2014-01-01 | SCHWARTZ JOHN J | Director | A-Award | A | Common Stock | 44,383 | 0.00 | — | 130,078 | — | ↗ |
| 2014-01-01 | SCHIFFMAN GREGORY T | Officer | — | D | no securities beneficially held at time of hire | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-01-01 | LEVY RICARDO B | Director | A-Award | A | Common Stock | 41,301 | 0.00 | — | 55,301 | — | ↗ |
| 2014-01-01 | GREER R SCOTT | Director | A-Award | A | Common Stock | 44,588 | 0.00 | — | 85,588 | — | ↗ |
| 2014-01-01 | BJERKHOLT ERIC | Director | A-Award | A | Common Stock | 47,164 | 0.00 | — | 69,164 | — | ↗ |
| 2013-12-20 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 643 | 1.00 | 643.00 | 151,673 | — | ↗ |
| 2013-10-01 | WEISSMAN IRVING | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 151,030 | — | ↗ |
Executive team
Top executives
Shares Outstanding
45.57M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Harel Gadot CEO, President & Chairman | 520.2K | 149.2K | — | 514.1K | — | 57.9K | 1.24M | 41.41% | ↗ |
| 2 | 2024 | Simon Sharon CTO and General Manager | 241.5K | 84.8K | — | 123.8K | — | 89.4K | 539.4K | 22.95% | ↗ |
| 3 | 2024 | Juan Diaz-Cartelle CMO | 350.0K | — | — | 26.5K | — | — | 376.5K | 7.03% | ↗ |
| 4 | 2024 | Rachel Vaknin CFO | 162.8K | 40.8K | — | 105.9K | — | 53.7K | 363.2K | 29.15% | ↗ |
| 5 | 2023 | Harel Gadot CEO, President & Chairman | 372.5K | 386.0K | — | 470.3K | — | 55.3K | 1.28M | 36.62% | ↗ |
| 6 | 2023 | Eyal Morag CMO | 146.4K | 82.9K | — | 101.4K | — | 181.2K | 511.9K | 19.80% | ↗ |
| 7 | 2023 | Simon Sharon CTO and General Manager | 195.9K | 87.0K | — | 88.4K | — | 98.6K | 469.9K | 18.82% | ↗ |
| 8 | 2023 | Rachel Vaknin CFO | 139.6K | 27.6K | — | 76.5K | — | 47.7K | 289.5K | 26.44% | ↗ |
| 9 | 2023 | Juan Diaz-Cartelle CMO | 14.8K | — | — | 720.00 | — | — | 15.5K | 4.64% | ↗ |
| 10 | 2022 | Harel Gadot CEO, President & Chairman | 514.0K | 300.0K | — | 971.2K | — | 52.9K | 1.84M | 52.84% | ↗ |
| 11 | 2022 | Eyal Morag CMO | 284.0K | 89.2K | — | 90.8K | — | 137.2K | 601.3K | 15.11% | ↗ |
| 12 | 2022 | Simon Sharon CTO and General Manager | 255.6K | 89.7K | — | 65.1K | — | 115.9K | 526.3K | 12.37% | ↗ |
| 13 | 2022 | Rachel Vaknin CFO | 142.0K | — | — | 45.3K | — | 47.4K | 234.6K | 19.29% | ↗ |
| 14 | 2021 | Harel Gadot CEO, President & Chairman | 534.0K | 300.0K | — | 959.6K | — | 13.8K | 1.81M | 53.09% | ↗ |
| 15 | 2021 | Eyal Morag Chief Medical Officer | 453.0K | 91.0K | — | 46.0K | — | 23.1K | 613.1K | 7.50% | ↗ |
| 16 | 2021 | Eyal Morag CMO | 453.0K | 91.0K | — | 46.0K | — | 23.1K | 613.1K | 7.50% | ↗ |
| 17 | 2021 | Simon Sharon CTO and General Manager | 365.5K | 110.3K | — | 58.1K | — | 26.1K | 560.0K | 10.38% | ↗ |
| 18 | 2021 | David Ben Naim Chief Financial Officer | 81.8K | — | — | — | — | — | 81.8K | 0.00% | ↗ |
| 19 | 2020 | Harel Gadot CEO, President & Chairman | 450.0K | 270.0K | — | 1.62M | — | 13.8K | 2.36M | 68.86% | ↗ |
| 20 | 2020 | Simon Sharon CTO and General Manager | 311.2K | 56.3K | — | 53.1K | — | 23.2K | 443.7K | 11.96% | ↗ |
| 21 | 2020 | Eyal Morag Chief Medical Officer | 243.0K | — | — | 21.6K | — | 7.1K | 271.7K | 7.96% | ↗ |
| 22 | 2020 | David Ben Naim Chief Financial Officer | 82.2K | — | — | 20.3K | — | — | 102.6K | 19.80% | ↗ |
| 23 | 2019 | Harel Gadot CEO, President & Chairman | 360.0K | 144.0K | — | 482.5K | — | 13.8K | 1.00M | 48.24% | ↗ |
| 24 | 2019 | Hezi Himelfarb Former Chief Operating Officer & General Manager | 201.9K | — | — | 322.1K | — | 8.1K | 532.1K | 60.54% | ↗ |
| 25 | 2019 | David Ben Naim Chief Financial Officer | 74.3K | — | — | 20.3K | — | — | 94.6K | 21.47% | ↗ |
| 26 | 2018 | Harel Gadot CEO, President & Chairman | 360.0K | 55.0K | — | 580.7K | — | 13.8K | 1.01M | 57.52% | ↗ |
| 27 | 2018 | Harel Gadot Chief Executive Officer | 360.0K | 55.0K | — | 580.7K | — | 13.8K | 1.01M | 57.52% | ↗ |
| 28 | 2018 | Hezi Himelfarb Former Chief Operating Officer & General Manager | 280.1K | 12.9K | — | 425.1K | — | 13.0K | 718.1K | 59.20% | ↗ |
| 29 | 2018 | David Ben Naim Chief Financial Officer | 70.0K | — | — | 26.9K | — | — | 96.9K | 27.75% | ↗ |
| 30 | 2017 | Harel Gadot Chief Executive Officer | 389.0K | 158.0K | — | 156.2K | — | 15.0K | 718.2K | 21.75% | ↗ |
| 31 | 2017 | Hezi Himelfarb Chief Operating Officer & General Manager | 228.7K | 40.6K | — | 92.2K | — | — | 361.5K | 25.51% | ↗ |
| 32 | 2017 | Hezi Himelfarb Former Chief Operating Officer & General Manager | 228.7K | 40.6K | — | 92.2K | — | — | 361.5K | 25.51% | ↗ |
| 33 | 2017 | David Ben Naim Chief Financial Officer | 66.0K | — | — | 188.00 | — | — | 66.2K | 0.28% | ↗ |
| 34 | 2016 | Harel Gadot Chief Executive Officer | 275.0K | — | — | — | — | — | 275.0K | 0.00% | ↗ |
| 35 | 2016 | Hezi Himelfarb Chief Operating Officer & General Manager | 16.0K | — | — | — | — | — | 16.0K | 0.00% | ↗ |
| 36 | 2016 | Hezi Himelfarb Former Chief Operating Officer & General Manager | 16.0K | — | — | — | — | — | 16.0K | 0.00% | ↗ |
| 37 | 2016 | David Ben Naim Chief Financial Officer | 6.0K | — | — | — | — | — | 6.0K | 0.00% | ↗ |
| 38 | 2015 | Martin McGlynn Former Chief Executive Officer | 570.0K | — | 1.91M | — | — | 44.4K | 2.52M | 75.65% | ↗ |
| 39 | 2015 | Ian Massey, D.Phil. President and Chief Executive Officer | 291.6K | 94.6K | 765.0K | — | — | 10.7K | 1.16M | 65.84% | ↗ |
| 40 | 2015 | Gregory Schiffman Chief Financial Officer and EVP of Finance | 450.0K | 180.0K | 487.9K | — | — | 28.1K | 1.15M | 42.57% | ↗ |
| 41 | 2015 | Ken Stratton, J.D. General Counsel | 320.0K | 102.4K | 364.8K | — | — | 33.5K | 820.7K | 44.45% | ↗ |
| 42 | 2015 | Harel Gadot Chief Executive Officer | 91.0K | — | — | — | — | — | 91.0K | 0.00% | ↗ |
| 43 | 2014 | Gregory Schiffman Chief Financial Officer and EVP of Finance | 450.0K | 157.5K | 458.5K | — | — | 28.1K | 1.09M | 41.91% | ↗ |
| 44 | 2014 | Gregory Schiffman Chief Financial Officer and EVP of Finance | 450.0K | 157.5K | 458.5K | — | — | 28.1K | 1.09M | 41.91% | ↗ |
| 45 | 2014 | Martin McGlynn Former Chief Executive Officer | 570.0K | 219.5K | — | — | — | 43.3K | 832.8K | 0.00% | ↗ |
| 46 | 2014 | Martin McGlynn Chief Executive Officer | 570.0K | 219.5K | — | — | — | 43.3K | 832.8K | 0.00% | ↗ |
| 47 | 2014 | Ken Stratton, J.D. General Counsel | 320.0K | 89.6K | — | — | — | 32.6K | 442.2K | 0.00% | ↗ |
| 48 | 2014 | Ken Stratton, J.D. General Counsel | 320.0K | 89.6K | — | — | — | 32.6K | 442.2K | 0.00% | ↗ |
| 49 | 2014 | Harel Gadot Chief Executive Officer | 184.0K | — | — | 186.0K | — | — | 370.0K | 50.27% | ↗ |
| 50 | 2013 | Martin McGlynn Former Chief Executive Officer | 550.0K | 287.4K | 1.24M | — | — | 43.3K | 2.12M | 58.45% | ↗ |
| 51 | 2013 | Martin McGlynn Chief Executive Officer | 550.0K | 287.4K | 1.24M | — | — | 43.3K | 2.12M | 58.45% | ↗ |
| 52 | 2013 | Martin McGlynn President and CEO | 548.5K | 287.4K | 1.24M | — | — | 43.3K | 2.12M | 58.50% | ↗ |
| 53 | 2013 | Ann Tsukamoto, Ph.D. EVP, Scientific and Strategic Alliances | 330.0K | 127.3K | 515.2K | — | — | 27.0K | 999.5K | 51.54% | ↗ |
| 54 | 2013 | Stewart Craig, Ph.D. EVP, Manufacturing Operations and Regulatory Affairs | 298.5K | 114.0K | 512.4K | — | — | 34.2K | 959.1K | 53.43% | ↗ |
| 55 | 2013 | Ken Stratton, J.D. General Counsel | 300.0K | 114.0K | 512.4K | — | — | 32.7K | 959.1K | 53.43% | ↗ |
| 56 | 2013 | Ken Stratton, J.D. General Counsel | 300.0K | 114.0K | 512.4K | — | — | 32.7K | 959.1K | 53.43% | ↗ |
| 57 | 2013 | Gregory Schiffman Chief Financial Officer and EVP of Finance | — | — | — | — | — | — | — | — | ↗ |
| 58 | 2012 | Martin McGlynn Chief Executive Officer | 550.0K | 202.1K | 430.4K | — | — | 50.6K | 1.23M | 34.90% | ↗ |
| 59 | 2012 | Martin McGlynn President and CEO | 548.1K | 202.1K | 430.4K | — | — | 50.6K | 1.23M | 34.96% | ↗ |
| 60 | 2012 | Ann Tsukamoto, Ph.D. EVP, Scientific and Strategic Alliances | 332.3K | 84.0K | 137.8K | — | — | 26.5K | 580.6K | 23.74% | ↗ |
| 61 | 2012 | Ken Stratton, J.D. General Counsel | 300.0K | 77.0K | 137.8K | — | — | 30.0K | 544.8K | 25.29% | ↗ |
| 62 | 2012 | Stewart Craig, Ph.D. EVP, Development and Operations | 300.0K | 77.0K | 137.8K | — | — | 29.9K | 544.7K | 25.30% | ↗ |
| 63 | 2012 | Stewart Craig, Ph.D. EVP, Manufacturing Operations and Regulatory Affairs | 298.1K | 77.0K | 137.8K | — | — | 29.9K | 542.7K | 25.39% | ↗ |
| 64 | 2012 | Rodney Young CFO and VP, Finance and Administration | 325.0K | 91.0K | — | — | — | 26.2K | 442.2K | 0.00% | ↗ |
| 65 | 2012 | Gregory Schiffman Chief Financial Officer and EVP of Finance | — | — | — | — | — | — | — | — | ↗ |
| 66 | 2011 | Martin McGlynn President and CEO | 525.0K | 187.7K | 194.0K | — | — | 48.8K | 955.5K | 20.30% | ↗ |
| 67 | 2011 | Rodney Young CFO and VP, Finance and Administration | 325.0K | 84.5K | — | — | — | 26.8K | 436.3K | 0.00% | ↗ |
| 68 | 2011 | Ann Tsukamoto, Ph.D. EVP, Scientific and Strategic Alliances | 300.0K | 78.0K | — | — | — | 24.4K | 402.4K | 0.00% | ↗ |
| 69 | 2011 | Ann Tsukamoto, Ph.D. EVP, Research and Development | 300.0K | 78.0K | — | — | — | 24.4K | 402.4K | 0.00% | ↗ |
| 70 | 2011 | Ken Stratton, J.D. General Counsel | 275.0K | 71.5K | — | — | — | 29.4K | 375.9K | 0.00% | ↗ |
| 71 | 2011 | Stewart Craig, Ph.D. EVP, Development and Operations | 275.0K | 71.5K | — | — | — | 27.9K | 374.4K | 0.00% | ↗ |
| 72 | 2011 | Stewart Craig, Ph.D. Senior VP, Development and Operations | 275.0K | 71.5K | — | — | — | 27.9K | 374.4K | 0.00% | ↗ |
| 73 | 2010 | Martin McGlynn President and CEO | 525.0K | 259.9K | 1.05M | 261.0K | — | 43.5K | 2.14M | 61.28% | ↗ |
| 74 | 2010 | Ann Tsukamoto, Ph.D. EVP, Scientific and Strategic Alliances | 300.0K | 81.0K | 714.0K | 169.0K | — | 24.6K | 1.29M | 68.52% | ↗ |
| 75 | 2010 | Ann Tsukamoto, Ph.D. EVP, Research and Development | 300.0K | 81.0K | 714.0K | 169.0K | — | 24.6K | 1.29M | 68.52% | ↗ |
| 76 | 2010 | Rodney Young CFO and VP, Finance and Administration | 325.2K | 87.8K | 204.0K | 42.3K | — | 24.3K | 683.5K | 36.03% | ↗ |
| 77 | 2010 | Stewart Craig, Ph.D. EVP, Development and Operations | 275.0K | 74.3K | 204.0K | 84.5K | — | 26.7K | 664.5K | 43.42% | ↗ |
| 78 | 2010 | Stewart Craig, Ph.D. Senior VP, Development and Operations | 275.0K | 74.3K | 204.0K | 84.5K | — | 26.7K | 664.5K | 43.42% | ↗ |
| 79 | 2010 | Ken Stratton, J.D. General Counsel | 275.1K | 74.3K | 204.0K | 42.3K | — | 25.7K | 621.3K | 39.63% | ↗ |
| 80 | 2009 | Martin McGlynn President and CEO | 540.9K | 202.1K | 410.7K | — | — | 38.6K | 1.32M | 31.01% | ↗ |
| 81 | 2009 | Rodney Young CFO and VP, Finance and Administration | 285.6K | 48.1K | 396.7K | 127.6K | — | 24.4K | 882.4K | 59.41% | ↗ |
| 82 | 2009 | Ann Tsukamoto, Ph.D. EVP, Research and Development | 311.5K | 52.5K | 163.3K | 52.5K | — | 21.6K | 601.5K | 35.89% | ↗ |
| 83 | 2009 | Stewart Craig, Ph.D. Senior VP, Development and Operations | 285.6K | 48.1K | 159.6K | 50.7K | — | 23.6K | 567.6K | 37.05% | ↗ |
| 84 | 2009 | Ken Stratton, J.D. General Counsel | 259.6K | 35.0K | 163.3K | — | — | 25.2K | 535.6K | 30.49% | ↗ |
| 85 | 2009 | Ann Tsukamoto, Ph.D EVP, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 86 | 2008 | Martin McGlynn President and CEO | 385.0K | 77.0K | 519.8K | — | — | 229.2K | 1.21M | 42.92% | ↗ |
| 87 | 2008 | Ann Tsukamoto, Ph.D. EVP, Research and Development | 300.0K | 37.5K | 259.9K | — | — | 21.6K | 619.0K | 41.99% | ↗ |
| 88 | 2008 | Rodney Young CFO and VP, Finance and Administration | 275.0K | 34.4K | 259.9K | — | — | 21.8K | 591.0K | 43.97% | ↗ |
| 89 | 2008 | Ken Stratton, J.D. General Counsel | 245.0K | 47.0K | 104.0K | — | — | 22.8K | 418.7K | 24.83% | ↗ |
| 90 | 2008 | Stewart Craig, Ph.D. Senior VP, Development and Operations | 74.0K | 10.1K | — | — | — | 5.2K | 275.8K | 0.00% | ↗ |
| 91 | 2008 | Ann Tsukamoto, Ph.D EVP, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 92 | 2007 | Rodney Young CFO and VP, Finance and Administration | — | — | — | — | — | — | — | — | ↗ |
| 93 | 2007 | Ann Tsukamoto, Ph.D EVP, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 94 | 2005 | Judi Lum Chief Financial Officer and | — | — | — | — | — | — | — | — | ↗ |
| 95 | 2005 | Ann Tsukamoto, Ph.D. VP, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 96 | 2005 | Rodney K.B. Young | — | — | — | — | — | — | — | — | ↗ |
| 97 | 2005 | Martin McGlynn President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 98 | 2004 | Judi Lum | 38.9K | — | — | — | — | 1.2K | 40.1K | 0.00% | ↗ |
| 99 | 2004 | Judi Lum Chief Financial Officer and | — | — | — | — | — | — | — | — | ↗ |
| 100 | 2004 | Ann Tsukamoto, Ph.D. VP, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 101 | 2004 | Martin McGlynn President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 102 | 2003 | Ann Tsukamoto, Ph.D. VP, Research and Development | — | — | — | — | — | — | — | — | ↗ |
| 103 | 2003 | Martin McGlynn President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 104 | 2002 | Martin McGlynn President and Chief Executive Officer | 286.0K | 75.0K | — | — | — | 241.6K | 602.6K | 0.00% | ↗ |
| 105 | 2002 | Martin McGlynn President and Chief | 286.0K | 75.0K | — | — | — | 241.6K | 602.6K | 0.00% | ↗ |
| 106 | 2002 | Ann Tsukamoto, Ph.D. VP, Research and Development | 200.1K | — | — | — | — | 7.2K | 207.2K | 0.00% | ↗ |
| 107 | 2001 | Martin McGlynn President and Chief Executive Officer | 264.4K | 68.8K | — | — | — | 147.4K | 480.5K | 0.00% | ↗ |
| 108 | 2001 | Martin McGlynn President and Chief | 264.4K | 68.8K | — | — | — | 147.4K | 480.5K | 0.00% | ↗ |
| 109 | 2001 | Ann Tsukamoto, Ph.D. VP, Research and Development | 183.8K | — | — | — | — | 5.3K | 189.1K | 0.00% | ↗ |
| 110 | 2000 | Ann Tsukamoto, Ph.D. VP, Research and Development | 159.1K | — | — | — | — | 4.8K | 163.8K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Harel Gadot | Co-Founder, President, Chief Executive Officer & Chairman | 1M | male |
| Simon Sharon | Chief Technology Officer & GM of Microbot Israel | 523.7K | — |
| Juan Diaz-Cartelle | Chief Medical Officer | 497.4K | — |
| Rachel Vaknin | Chief Financial Officer | 376.1K | female |
| Naama Moav | Vice President of Human Resources | — | — |
| Michael Lytle | Head of Sales Operations & Analytics | — | male |
| Christina Bailey | Vice President of Sales | — | female |
| Allison Rosefort | Vice President of Marketing | — | female |
| Michal Ahuvia | Director of Operations | — | female |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MBOT
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
